Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Merck & Co., Inc.

MRKNYSE
Healthcare
Drug Manufacturers - General
$121.86
$0.00(0.00%)
U.S. Market is Open • 15:50

Merck & Co., Inc. (MRK) Stock Overview

Explore Merck & Co., Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap305.4B
P/E Ratio16.68
EPS (TTM)$7.28
ROE0.36%
Fundamental Analysis

AI Price Forecasts

1 Month$116.85
3 Months$111.28
1 Year Target$139.88

MRK Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Merck & Co., Inc. (MRK) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of A, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 70.96, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $139.88.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 16.68 and a market capitalization of 305.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.34%
5-Day Change
0.64%
1-Month Change
11.72%
3-Month Change
28.76%
6-Month Change
44.44%
Year-to-Date (YTD) Change
14.87%
1-Year Change
39.46%
3-Year Change
12.11%
5-Year Change
71.14%
All-Time (Max) Change
30827.99%

Contact Information

908 740 4000
2000 Galloping Hill Road, Rahway, NJ, 07033

Company Facts

730,000 Employees
IPO DateJan 13, 1978
CountryUS
Actively Trading

Frequently Asked Questions